MedTrace Logo

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

NCT00095589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2019-02-08

No results posted yet for this study

Summary

RATIONALE: New diagnostic procedures such as microsatellite analysis of sediment in the urine may improve the ability to detect bladder cancer without invasive procedures.

PURPOSE: Diagnostic trial to study the effectiveness of microsatellite analysis of sediment in the urine in detecting bladder cancer in healthy participants, participants who have genitourinary conditions requiring cystoscopy, and patients who have bladder cancer.

Conditions

Interventions

GENETIC

loss of heterozygosity analysis

GENETIC

microarray analysis

GENETIC

microsatellite instability analysis

OTHER

cytology specimen collection procedure

OTHER

laboratory biomarker analysis

PROCEDURE

computed tomography

PROCEDURE

cystoscopy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Mark P. Schoenberg, MD · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Eligibility

Min Age
40 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00095589 on ClinicalTrials.gov